Praxis Precision Medicines (PRAX) Other Gross PP&E Adjustments (2019 - 2026)
Praxis Precision Medicines' quarterly Other Gross PP&E Adjustments came in at -$1.3 million in Q1 2026, down 49.66% year-on-year from -$2.6 million in Q1 2025, and up 83.4% quarter-over-quarter from -$8.0 million in Q4 2025.
Praxis Precision Medicines has reported Other Gross PP&E Adjustments for 8 years, with the latest figure at -$1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Other Gross PP&E Adjustments fell 49.66% year-over-year to -$1.3 million; the trailing twelve-month figure through Mar 2026 stood at -$1.3 million (down 49.66% YoY), and the FY2025 full-year result was -$8.0 million, up 4.46% from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 stood at -$1.3 million, up from -$8.0 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was -$362000.0 in Q3 2025, with the low at -$8.3 million in Q4 2024.
- Average Other Gross PP&E Adjustments over 5 years is -$3.4 million, with a median of -$2.5 million recorded in 2023.
- Year-over-year, Other Gross PP&E Adjustments plunged 508.23% in 2022 and soared 73.65% in 2025.
- Tracing PRAX's Other Gross PP&E Adjustments over 5 years: stood at -$7.8 million in 2022, then fell by 4.99% to -$8.2 million in 2023, then retreated by 1.89% to -$8.3 million in 2024, then gained by 4.46% to -$8.0 million in 2025, then jumped by 83.4% to -$1.3 million in 2026.
- The last three Other Gross PP&E Adjustments figures came in at -$1.3 million (Q1 2026), -$8.0 million (Q4 2025), and -$362000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Praxis Precision Medicines | 10.11 Bn | 9.32 Bn | - | -1.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.32 Mn |
| Mar 31, 2026 | -1.32 Mn |
| Dec 31, 2025 | -7.95 Mn |
| Dec 31, 2025 | -7.95 Mn |
| Sep 30, 2025 | -362,000.00 |
| Sep 30, 2025 | -362,000.00 |
| Jun 30, 2025 | -626,000.00 |
| Jun 30, 2025 | -626,000.00 |
| Mar 31, 2025 | -882,000.00 |
| Mar 31, 2025 | -882,000.00 |
| Dec 31, 2024 | -8.32 Mn |
| Dec 31, 2024 | -8.32 Mn |
| Sep 30, 2024 | -1.37 Mn |
| Sep 30, 2024 | -1.37 Mn |
| Jun 30, 2024 | -1.61 Mn |
| Jun 30, 2024 | -1.61 Mn |
| Mar 31, 2024 | -1.84 Mn |
| Mar 31, 2024 | -1.84 Mn |
| Dec 31, 2023 | -8.17 Mn |
| Dec 31, 2023 | -8.17 Mn |
| Sep 30, 2023 | -2.28 Mn |
| Sep 30, 2023 | -2.28 Mn |
| Jun 30, 2023 | -2.49 Mn |
| Jun 30, 2023 | -2.49 Mn |
| Mar 31, 2023 | -2.70 Mn |
| Mar 31, 2023 | -2.70 Mn |
| Dec 31, 2022 | -7.78 Mn |
| Dec 31, 2022 | -7.78 Mn |
| Sep 30, 2022 | -3.10 Mn |
| Sep 30, 2022 | -3.10 Mn |
| Jun 30, 2022 | -3.29 Mn |
| Jun 30, 2022 | -3.29 Mn |
| Mar 31, 2022 | -3.47 Mn |
| Mar 31, 2022 | -3.47 Mn |
| Dec 31, 2021 | -6.05 Mn |
| Dec 31, 2021 | -6.05 Mn |
| Sep 30, 2021 | -4.03 Mn |
| Sep 30, 2021 | -4.03 Mn |
| Jun 30, 2021 | -4.40 Mn |
| Jun 30, 2021 | -4.40 Mn |
| Mar 31, 2021 | -571,000.00 |
| Mar 31, 2021 | -571,000.00 |
| Dec 31, 2020 | -754,000.00 |
| Dec 31, 2020 | -754,000.00 |
| Sep 30, 2020 | -933,000.00 |
| Sep 30, 2020 | -933,000.00 |
| Dec 31, 2019 | -1.34 Mn |
| Dec 31, 2019 | -1.34 Mn |